JP2006526626A5 - - Google Patents

Download PDF

Info

Publication number
JP2006526626A5
JP2006526626A5 JP2006509916A JP2006509916A JP2006526626A5 JP 2006526626 A5 JP2006526626 A5 JP 2006526626A5 JP 2006509916 A JP2006509916 A JP 2006509916A JP 2006509916 A JP2006509916 A JP 2006509916A JP 2006526626 A5 JP2006526626 A5 JP 2006526626A5
Authority
JP
Japan
Prior art keywords
phase
dispersion
dispersed
continuous
organic nanoparticles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006509916A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006526626A (ja
Filing date
Publication date
Priority claimed from US10/449,677 external-priority patent/US7109247B2/en
Application filed filed Critical
Publication of JP2006526626A publication Critical patent/JP2006526626A/ja
Publication of JP2006526626A5 publication Critical patent/JP2006526626A5/ja
Pending legal-status Critical Current

Links

JP2006509916A 2003-05-30 2004-04-12 ナノ粒子を含有する安定化された粒子分散液 Pending JP2006526626A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/449,677 US7109247B2 (en) 2003-05-30 2003-05-30 Stabilized particle dispersions containing nanoparticles
PCT/US2004/011181 WO2005002544A2 (en) 2003-05-30 2004-04-12 Stabilized particle dispersions containing nanoparticles

Publications (2)

Publication Number Publication Date
JP2006526626A JP2006526626A (ja) 2006-11-24
JP2006526626A5 true JP2006526626A5 (https=) 2007-04-26

Family

ID=33451844

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006509916A Pending JP2006526626A (ja) 2003-05-30 2004-04-12 ナノ粒子を含有する安定化された粒子分散液

Country Status (6)

Country Link
US (3) US7109247B2 (https=)
EP (1) EP1628635A2 (https=)
JP (1) JP2006526626A (https=)
KR (1) KR20060038937A (https=)
CN (1) CN1798543A (https=)
WO (1) WO2005002544A2 (https=)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7109247B2 (en) * 2003-05-30 2006-09-19 3M Innovative Properties Company Stabilized particle dispersions containing nanoparticles
US20040242729A1 (en) * 2003-05-30 2004-12-02 3M Innovative Properties Company Stabilized particle dispersions containing surface-modified inorganic nanoparticles
US7459146B2 (en) * 2003-05-30 2008-12-02 3M Innovative Properties Company Stabilized aerosol dispersions
WO2004112799A1 (en) * 2003-06-13 2004-12-29 Chrysalis Technologies Incorporated Methods and apparatus for producing nanoscale particles
US7470650B2 (en) * 2003-10-15 2008-12-30 Ashland Licensing And Intellectual Property Llc Shock absorber fluid composition containing nanostructures
US7723438B2 (en) * 2005-04-28 2010-05-25 International Business Machines Corporation Surface-decorated polymeric amphiphile porogens for the templation of nanoporous materials
US20070292688A1 (en) * 2005-08-18 2007-12-20 Eastman Kodak Company Silylamine modified nanoparticulate carriers
US20100119697A1 (en) * 2006-05-10 2010-05-13 3M Innovative Properties Company Compositions and coatings containing fluorescent, inorganic nanoparticles
US8527313B2 (en) * 2006-05-15 2013-09-03 Sap Ag Document instantiation triggering a business action
US20070276714A1 (en) * 2006-05-15 2007-11-29 Sap Ag Business process map management
US20080166558A1 (en) * 2006-12-22 2008-07-10 3M Innovative Properties Company Compositions of particles
US20080153963A1 (en) * 2006-12-22 2008-06-26 3M Innovative Properties Company Method for making a dispersion
US20080152913A1 (en) * 2006-12-22 2008-06-26 3M Innovative Properties Company Method of making compositions including particles
US8250169B2 (en) * 2007-09-24 2012-08-21 Sap Ag Business context data companion tool
US8127237B2 (en) * 2007-09-24 2012-02-28 Sap Ag Active business client
US8131668B2 (en) * 2008-05-28 2012-03-06 Sap Ag User-experience-centric architecture for data objects and end user applications
CN102272277A (zh) 2008-12-30 2011-12-07 3M创新有限公司 润滑剂组合物及形成方法
US8741819B2 (en) 2008-12-30 2014-06-03 3M Innovative Properties Company Composite particles and method of forming
US8782530B2 (en) * 2009-03-25 2014-07-15 Sap Ag Method and system for providing a user interface in a computer
US8712953B2 (en) * 2009-03-25 2014-04-29 Sap Ag Data consumption framework for semantic objects
US20110031430A1 (en) * 2009-08-07 2011-02-10 University Of Florida Research Foundation Inc. Synthesis of water-soluble organic nanoparticles as epr standard
CN102639665B (zh) * 2009-12-03 2015-04-01 3M创新有限公司 粒子的静电沉积方法、磨粒以及制品
US8722796B2 (en) * 2010-01-20 2014-05-13 Basf Se Process for preparing an aqueous polymer dispersion
EP2526124B1 (de) 2010-01-20 2014-03-19 Basf Se Verfahren zur herstellung einer wässrigen polymerisatdispersion
US8211450B2 (en) 2010-05-05 2012-07-03 Senju Usa, Inc. Ophthalmic composition
US8835363B2 (en) 2010-06-16 2014-09-16 Saudi Arabian Oil Company Drilling, drill-in and completion fluids containing nanoparticles for use in oil and gas field applications and methods related thereto
JP5968310B2 (ja) 2010-06-24 2016-08-10 スリーエム イノベイティブ プロパティズ カンパニー 有機乳化剤を含まない重合性組成物、並びにそのポリマー及び製造方法
CN102416179B (zh) 2010-09-28 2014-05-07 益得生物科技股份有限公司 用于哮喘的吸入性复方组合物
WO2012047691A2 (en) * 2010-10-04 2012-04-12 3M Innovative Properties Company Method of modifying dissolution rate of particles by addition of hydrophobic nanoparticles
US20120310140A1 (en) 2010-12-01 2012-12-06 Spinal Modulation, Inc. Directed delivery of agents to neural anatomy
EP2778221B1 (en) 2011-02-07 2017-07-26 Life Technologies Corporation Compositions and methods for stabilizing susceptible compounds
US8694911B2 (en) * 2011-11-28 2014-04-08 International Business Machines Corporation Manipulating hidden data entries via representative markers
US20160279055A1 (en) 2013-07-22 2016-09-29 Imprimis Pharmaceuticals, Inc. Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabricating thereof
US20150164882A1 (en) 2013-07-22 2015-06-18 Imprimis Pharmaceuticals, Inc. Pharmaceutical compositions for intraocular administration and methods for fabricating thereof
WO2015066717A1 (en) 2013-11-04 2015-05-07 BioPharmX, Inc. Dosage form comprising an active ingredient and a plurality of solid porous microcarriers
CA3023243C (en) * 2016-05-06 2020-01-21 Imprimis Pharmaceuticals, Inc. Pharmaceutical ophthalmic compositions and methods for fabricating thereof
US20180043017A1 (en) * 2016-08-11 2018-02-15 Xtl Biopharmaceuticals Ltd. Pharmaceutical compositions comprising 0.5 mg dose of synthetic human peptides for treating systemic lupus erythematosus
CL2017001945A1 (es) * 2017-07-30 2018-10-19 Univ Tecnica Federico Santa Maria Utfsm Método, proceso, composición y kit para medir concentración de moléculas disueltas en la fase continua de un coloide.
CL2018001473A1 (es) * 2018-06-01 2019-10-25 Univ Tecnica Federico Santa Maria Utfsm Kit y métodos para evaluar las propiedades adsorbentes de la superficie de un material
KR20210084472A (ko) * 2018-10-30 2021-07-07 크로다 인코포레이티드 수성 또는 극성 용매 중에 미세 입자를 분산시키는 방법
CN115227833B (zh) * 2022-07-29 2023-03-21 西安交通大学医学院第一附属医院 一种氟化二氧化硅载药纳米粒及其制备方法、用途
WO2024182731A1 (en) * 2023-03-01 2024-09-06 Nevakar Injectables Inc. Injectable compositions of vitamers of vitamin b12 and uses thereof

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE837243C (de) 1944-09-30 1952-04-21 Bayer Ag Schwebemittel fuer waessrige Suspensionen
US2801185A (en) 1952-05-16 1957-07-30 Du Pont Silica hydrosol powder
DE1467023A1 (de) 1964-02-28 1969-01-23 Degussa Verfahren zur Inkorporierung von Wasser in feinst verteilter Kieselsaeure
US4680173A (en) 1977-04-28 1987-07-14 Norman D. Burger Aerosol dispensing system
US4522958A (en) 1983-09-06 1985-06-11 Ppg Industries, Inc. High-solids coating composition for improved rheology control containing chemically modified inorganic microparticles
DE3333639A1 (de) 1983-09-17 1985-03-28 Dynamit Nobel Ag Zubereitung von nitroestern fuer die koronartherapie
FR2666962B1 (fr) 1990-09-26 1996-06-14 Oreal Composition antifongique sous forme de spray sec.
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
FR2677544B1 (fr) 1991-06-14 1993-09-24 Oreal Composition cosmetique contenant un melange de nanopigments d'oxydes metalliques et de pigments melaniques.
FR2698002B1 (fr) * 1992-11-13 1995-01-13 Oreal Composition cosmétique de maquillage contenant un fullerène ou un mélange de fullerènes comme agent pigmentant.
IL108416A (en) 1993-01-25 1998-10-30 Sonus Pharma Inc Phase shift colloids as ultrasound contrast agents
US5492688A (en) 1993-04-28 1996-02-20 The Center For Innovative Technology Metered dose inhaler fomulations which include the ozone-friendly propellant HFC 134a and a pharmaceutically acceptable suspending, solubilizing, wetting, emulsifying or lubricating agent
JP3756213B2 (ja) * 1995-02-27 2006-03-15 独立行政法人科学技術振興機構 微粒子膜とその形成方法並びにその装置
IT1275955B1 (it) 1995-03-22 1997-10-24 Dompe Spa Formulazioni farmaceutiche in forma di gel tissotropico
US5672662A (en) 1995-07-07 1997-09-30 Shearwater Polymers, Inc. Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
FR2746302B1 (fr) * 1996-03-20 1998-12-24 Oreal Compositions cosmetiques comprenant des nanopigments
FR2759582A1 (fr) * 1997-02-14 1998-08-21 Oreal Composition deodorante
GB9711625D0 (en) * 1997-06-06 1997-07-30 Ciba Geigy Ag Pigment compositions
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
DE19811790A1 (de) * 1998-03-18 1999-09-23 Bayer Ag Nanopartikel enthaltende transparente Lackbindemittel mit verbesserter Verkratzungsbeständigkeit, ein Verfahren zur Herstellung sowie deren Verwendung
FR2781373B1 (fr) 1998-07-07 2001-09-21 Pf Medicament Formulations thixotropes pour le remplissage de gelules
DE69827166T2 (de) 1998-07-30 2006-02-23 Minnesota Mining & Manufacturing Company, St. Paul Metalloxid teilchen im nano-bereich für die herstellung von metalloxidkolloiden und ceramers
US6319513B1 (en) 1998-08-24 2001-11-20 The Procter & Gamble Company Oral liquid mucoadhesive compounds
US7521068B2 (en) 1998-11-12 2009-04-21 Elan Pharma International Ltd. Dry powder aerosols of nanoparticulate drugs
US6258896B1 (en) * 1998-12-18 2001-07-10 3M Innovative Properties Company Dendritic polymer dispersants for hydrophobic particles in water-based systems
US6270806B1 (en) * 1999-03-03 2001-08-07 Elan Pharma International Limited Use of peg-derivatized lipids as surface stabilizers for nanoparticulate compositions
ES2293913T3 (es) 1999-07-20 2008-04-01 THE PROCTER & GAMBLE COMPANY Particulas de aceite encapsulado mejoradas.
AU776770B2 (en) 1999-12-03 2004-09-23 Kuraray Co., Ltd. Dental or oralogic composition
JP4665322B2 (ja) * 2000-03-16 2011-04-06 東レ株式会社 ポリ（脂環式オレフィン）
PT1280520E (pt) 2000-05-10 2014-12-16 Novartis Ag Pós à base de fosfolípidos para administração de fármacos
FR2808704B1 (fr) * 2000-05-10 2002-08-16 Rhodia Chimie Sa Agents tensioactifs formes par des particules minerales de dimension nanometrique de surface modifiee
ES2260299T3 (es) 2000-10-09 2006-11-01 3M Innovative Properties Company Formulaciones medicinales en aerosol.
US20040081627A1 (en) * 2000-10-09 2004-04-29 Jinks Phillip A Medicinal aerosol formulations
US6467897B1 (en) 2001-01-08 2002-10-22 3M Innovative Properties Company Energy curable inks and other compositions incorporating surface modified, nanometer-sized particles
US6586483B2 (en) 2001-01-08 2003-07-01 3M Innovative Properties Company Foam including surface-modified nanoparticles
JP4293735B2 (ja) * 2001-01-19 2009-07-08 三栄源エフ・エフ・アイ株式会社 フラーレン誘導体およびそれからなる組成物
CN1487852A (zh) * 2001-01-19 2004-04-07 �����ɷ� 分散剂
FR2830450B1 (fr) 2001-10-09 2004-02-06 Univ Pasteur Utilisation de dendrimeres dans une composition ophtalmique
EP1458365A1 (en) * 2001-12-21 2004-09-22 Celator Technologies Inc. Improved polymer-lipid delivery vehicles
US7141612B2 (en) 2002-12-31 2006-11-28 3M Innovative Properties Company Stabilized foams including surface-modified organic molecules
US7001580B2 (en) * 2002-12-31 2006-02-21 3M Innovative Properties Company Emulsions including surface-modified organic molecules
US7129277B2 (en) * 2002-12-31 2006-10-31 3M Innovative Properties Company Emulsions including surface-modified inorganic nanoparticles
US20040242729A1 (en) 2003-05-30 2004-12-02 3M Innovative Properties Company Stabilized particle dispersions containing surface-modified inorganic nanoparticles
US7459146B2 (en) 2003-05-30 2008-12-02 3M Innovative Properties Company Stabilized aerosol dispersions
US7109247B2 (en) 2003-05-30 2006-09-19 3M Innovative Properties Company Stabilized particle dispersions containing nanoparticles

Similar Documents

Publication Publication Date Title
JP2006526626A5 (https=)
JP2007500209A5 (https=)
JP2008044951A5 (https=)
IL194885A0 (en) Pharmaceutical combination comprising 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol and an nsaid
WO2007117661A3 (en) Drug microparticles
JP2007513165A5 (https=)
JP2009506076A5 (https=)
JP2007527914A5 (https=)
JP2005507881A5 (https=)
JP2005518433A5 (https=)
ATE494889T1 (de) Pharmazeutische kombination mit 3- (3- dimethylamino-1-ethyl-2-methyl-propyl)-phenol und paracetamol
JP2007517055A5 (https=)
JP2010535252A5 (https=)
WO2007112274A3 (en) Formulations of low dose non-steroidal anti-inflammatory drugs and beta-cyclodextrin
EP2326331A4 (en) NEW LIPID NANOPARTICLES AND NEW COMPONENTS FOR THE RELEASE OF NUCLEIC ACIDS
JP2006526624A5 (https=)
JP2007504174A5 (https=)
JP2009500443A5 (https=)
EA201100305A1 (ru) Лечение респираторных заболеваний
JP2008505857A5 (https=)
WO2006050002A3 (en) Compositions for controlled delivery of pharmaceutically active compounds
WO2006088814A3 (en) Dosage form and method for sustained release of a substituted pyrazine compound
WO2006041538A3 (en) A mixture for transdermal delivery of low and high molecular weight compounds
AR059225A1 (es) Sal de citrato, proceso de preparacion y su actividad en terapia
JP2009534367A5 (https=)